<DOC>
	<DOC>NCT01526564</DOC>
	<brief_summary>Chemotherapy-induced peripheral neuropathy (CIPN) is a common clinical dose-limiting adverse drug reaction, and the primary manifestations are different degree of neuromotor, sensorineural and autonomic nervous dysfunction.</brief_summary>
	<brief_title>Clinical Study on Acetyl-L-Carnitine</brief_title>
	<detailed_description>This multicenter, randomized, double-blind, placebo-controlled and parallel clinical trial is to observe the efficacy and safety of the Acetyl-L-Carnitine Hydrochloride enteric-coated tablets in treatment of peripheral sensory neuropathy that anti-cancer chemotherapeutics induce.</detailed_description>
	<mesh_term>Acetylcarnitine</mesh_term>
	<criteria>Patients had signed the Informed Consent Form Male or Female Age 1875 years old Patients who have treated with Taxoids, Satraplatin and Vincristine; The peripheral sensory neuropathy grading after chemotherapy was &gt;/=grade 3 or grade 2 lasting for one month The course of neuropathy was &lt;/=6 months No need to continue chemotherapy according to the condition nor refusing chemotherapy At least one of the neuroelectrophysiological examine results were abnormal Physical Condition Score (KPS) &gt;/=60 Anticipated lifetime&gt;/=60. Patients whose peripheral sensory neuropathy was induced by medicines except of the Taxoids, Satraplatin and vincristine anticancer chemotherapeutics Diabetics Peripheral sensory neuropathy was induced by Vitamin deficiency, infections, trauma, toxicosis, compression, and ischemia Peripheral sensory neurologic dysfunction that induced by lesions of central nervous system; hereditary neuropathy Patients who have treated by other medicines for peripheral sensory neuropathy in 30 days Patients had treated by other clinical trial medicines or participated into other trials in 30 days Patients had active infections Any clinical problems out of control Women in pregnancy and lactation, Subjects with no compliance.</criteria>
	<gender>All</gender>
	<minimum_age>18 Weeks</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Chemotherapy-induced peripheral neuropathy (CIPN)</keyword>
</DOC>